While semaglutide is not specifically known to cause major mood changes, some people have reported mild anxiety, fatigue, or irritability
Therefore, supplementing with glutathione can be beneficial for many individuals
Patients taking insulin or sulfonylureas should be monitored for hypoglycemia risk, as Zepbound may potentiate their glucose-lowering effects
GLP-1 receptor agonists, including semaglutide, are known to improve multiple cardiovascular risk factors, such as blood pressure, lipid profiles, inflammation, body weight, central adiposity, and glycemic control, even in non-diabetic or prediabetic people
The journey doesnt end when you reach your goal weightongoing support is key to sustaining your achievements